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ObituaryLeo Lefranc¸ois (1956–2013)Leo Lefranc¸oisLeo Lefranc¸ois died of a sudden cardiac
event on July 20, 2013, while hiking in
the Italian Dolomites with his wife and
fellow immunologist, Lynn Puddington,
and friends. Leo was a pioneering cellular
immunologist with broad interests in
CD8+ memory T cells, mucosal immu-
nology, and gamma-delta T cell biology.
He eschewed overly reductionist appro-
aches and understood that a deep under-
standing of immunity would require the
use of new tools with the capacity to track
antigen-specific lymphocytes within
hosts responding to natural infectious
agents. He was therefore quick to take
advantage and develop transgenic and
gene-targeted mouse models, adoptive
transfer of T cell receptor (TCR) trans-
genic T cells, and peptide:MHCI tetra-
mers to track T cells ex vivo by flow
cytometry or in situ by immunofluores-
cence. By studying immunity to infection,
he was ahead of a field focused on im-
mune responses to purified model
antigens, and by using these tools, Leo
greatly advanced the understanding
of key aspects of the adaptive T cell
response through many highly influential
publications. Leo was one of the brightest
stars of his scientific generation.
Leo’s career in immunology spanned
three decades. He worked as a Medical
Technologist for several years after grad-
uating with a B.S. in Microbiology and
Medical Technology from Colorado State
University in 1978. Close involvement with
microbial and viral agents during this
period likely influenced Leo’s later focus
on mechanisms of immunity to infectious
disease.
Leo undertook Ph.D. studies inMicrobi-
ology and Immunology at Wake Forest
University, where he received a Ph.D. in
1982. Working with Douglas Lyles, he
studied several aspects of the cell-medi-
ated and humoral immune responses to
vesicular stomatitis virus (VSV). His char-
acterization of antibody epitopes on the
major surface glycoprotein of the virus
was the basis for the study of immunity
to VSV.
He then pursued postdoctoral studies
with Michael Bevan in the Department of
Immunology at the Scripps Clinic and
Research Foundation in La Jolla, CA. Hestudied the basic cell biology of cytotoxic
T cells and characterized their heteroge-
neity by using the superabundant and
multiform CD45 protein (then, T200)—
now known to be a cell-surface phospha-
tase. He also clarified the role that CD8+
T cells play in allograft rejection. These
studies were described in a remarkable
11 first or last author publications.
Leo then took a position as a Research
Scientist in the Department of Cell Biology
at The Upjohn Company in Kalamazoo,
MI, and worked there until 1991. During
his time at Upjohn, Leo changed his
research emphasis entirely and carried
out pioneering work on gamma-delta
T cells. It was here that Leo initiated his
long interest in the mucosal immune
system, and he found that intestinal
epithelial lymphocytes largely expressed
the gamma-delta T cell antigen receptor.
It is a testament to Leo’s persuasiveness
that a 100-year-old pharmaceutical
company known for cortisone synthesis
allowed his work on T cell subsets found
within mouse gut epithelium. These early
Lefranc¸ois studies set the stage for a
series of highly cited papers showing
that the anatomic location of gamma-
delta T cells influences their function in
part as a consequence of exposure to
commensal microbes. His work on
gamma-delta T cells culminated with the
recent discovery of the means to elicit
protective memory in gut gamma-delta
T cells.
Leo changed direction again in 1992
when he took a position as an AssociateImmunity 39, SeProfessor at the University of Connecticut
Health Center. Here his already stellar
career accelerated as he focused on the
alpha-beta CD8+ T cell response to infec-
tion. In a now classic study, Lefrancois
and then graduate student David
Masopust showed that peptide:MHCI-
specific CD8+ T cells induced by viral or
bacterial infection are primed in second-
ary lymphoid organs and then migrate in
large numbers to nonlymphoid tissues.
Furthermore, the CD8+ memory T cells
present in nonlymphoid tissues were
more cytolytic than the ones with the
same peptide:MHCI-specificity in the
spleen. By revealing the existence of
nonlymphoid CD8+ effector-memory
T cells positioned for immediate response
to the inducing infection, this seminal
work laid the groundwork for current
investigations of tissue-resident memory
cells and vaccine strategies aimed at
generating this population. Now that this
one Science article has been cited more
than 1,000 times, it is easy to forget how
ignored the nonlymphoid lives of T cells
were before Leo’s work. Leo’s studies
on the peptide:MHCI-specific CD8+
T cell response to oral infection with
Listeria monocytogenes also highlighted
the important roles that CD8+ memory
T cells and dendritic cells play in the intes-
tinal mucosa.
Leo’s group made seminal contribu-
tions to the current understanding of
CD8+ T cell survival and homeostasis. In
another highly cited study, Leo and col-
leagues demonstrated the importance of
the cytokine interleukin-7 (IL-7) in main-
taining the interphase survival of naive
and memory T cells. They went on to
show that IL-7 could drive the proliferation
of naive and memory T cells in lympho-
penic hosts. The knowledge that IL-7 is a
key survival cytokine for T cells is now be-
ing used to speed immune reconstitution
in patients who have undergone cytotoxic
regimens. His group also showed that IL-
15 was important for the generation and
the subsequent maintenance of CD8+
memory T cells induced by virus infection.
Like many investigators, Leo used the
method of transferring T cells from TCR
transgenic T cells into adoptive hosts to
study the in vivo immune response ofptember 19, 2013 ª2013 Elsevier Inc. 415
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report, however, Leo established an
important concept in experimental immu-
nology. He and colleagues showed that
transferring a million monoclonal CD8+
T cells into a host caused intraclonal com-
petition and a skewed immune response.
These results have important implications
with respect to the differentiation of
effector and memory precursor cells and
explicitly pointed out the need to do
morephysiologically relevant experiments
involving fewer transferred monoclonal
T cells. Leo followed his own lead, recently
doing insightful experiments that revealed
the differentiation of single naive T cells.
Leo’s scientific contributions were
recognized by his election to the Amer-
ican Association for the Advancement of
Science and the Connecticut Academy
of Science and Engineering and invi-
tations to give prestigious lectures,
including the Grand Marnier Foundation416 Immunity 39, September 19, 2013 ª2013Guest Scientist in Residence at the
Pasteur Institute in Paris and the Daisuke
Nakada Memorial Lecture at the Univer-
sity of Pittsburgh. Leo gave back to the
community through service to the Amer-
ican Association of Immunologists, the
Society for Mucosal Immunology, and
the American Society for Microbiology.
He served as an Associate Editor for the
Journal of Immunology from 1990 to
1994 and as a Section Editor from 1995
to 2000.
Leo was a basic scientist, and we know
that he wanted to be judged as one. A
simple test of the importance of a basic
scientist’s work comes from the thought
experiment of what it would be like to
teach their discipline without their contri-
butions. What would it be like to teach
modern immunology if we did not know
that effector T cells migrate to nonlym-
phoid organs after activation, that T cells
are maintained by IL-7, and that gamma-Elsevier Inc.delta T cells are abundant in epithelial
layers? These important discoveries will
contribute to the education of immu-
nology students around the world.
There is no doubt that the field is poorer
for Leo’s passing as his scientific produc-
tivity and influence were still ascending.
We will remember Leo as the quintessen-
tial cellular immunologist, a wonderful
colleague, and a sincere friend. He was
a man of many interests, both scientific
and nonscientific, and he enjoyed sharing
those interests with friends and col-
leagues. He was serious about his work
but lacked interest in self-promotion.
These qualities motivated his students
and endeared him to his peers. If we can
find any consolation in his death, it is the
knowledge that he died living his life to
the fullest, doing something that he loved
in the company of his wife and friends.
Although his scientific legacy will live on,
we will miss him greatly.Marc K. Jenkins1,*
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